We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| MetLife Inc | NYSE:MET | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -0.09 | -0.13% | 71.61 | 71.67 | 71.15 | 71.30 | 275,841 | 15:27:56 |
From Apr 2019 to Apr 2024
By Kimberly Chin
MetLife Inc. has named James Reid as the chief executive officer of subsidiary Versant Health, effective April 1.
He will succeed Kirk Rothrock, who intends to retire. Mr. RothRock has been with the company for eight years and led the consolidation and integration of Superior Vision, Block Vision and Davis Vision into Versant Health. He will remain with the company until March 31 to help with the transition.
Most recently, Mr. Reid served as the head of Global Employee Benefits. where he helped build relationships and partnerships with multinational corporations as well as distribution relationships with financial institutions.
Versant Health is a managed vision care company.
Write to Kimberly Chin at kimberly.chin@wsj.com
(END) Dow Jones Newswires
January 14, 2021 13:23 ET (18:23 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year MetLife Chart |
1 Month MetLife Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
